Cargando…

β blockers for heart failure

End under-prescribing for women and older adults

Detalles Bibliográficos
Autor principal:	Hoes, Arno W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849167/ https://www.ncbi.nlm.nih.gov/pubmed/27099266 http://dx.doi.org/10.1136/bmj.i2074

Ejemplares similares

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Epidemiology of heart failure
por: Groenewegen, Amy, et al.
Publicado: (2020)

β-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational Study
por: Rutten, Frans H., et al.
Publicado: (2013)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017)

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
por: Oomman, Abraham, et al.
Publicado: (2018)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022)

β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure
por: Feuerstein, Thomas J., et al.
Publicado: (2021)

Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
por: Cho, Jae Yeong
Publicado: (2019)

Should We Use Dialyzable β-Blockers in Hemodialysis?
por: Georgianos, Panagiotis I., et al.
Publicado: (2022)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy
por: Lymperopoulos, Anastasios, et al.
Publicado: (2017)

Search for HRV-parameters that detect a sympathetic shift in heart failure patients on β-blocker treatment
por: Zhang, Yanru, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Groenewegen, Amy, et al.
Publicado: (2021)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

COPD in patients with stable heart failure in the primary care setting
por: Valk, Mark J, et al.
Publicado: (2015)

β-blockers in hemodialysis: simple questions, complicated answers
por: Hundemer, Gregory L, et al.
Publicado: (2020)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019)

Evaluation of β-blocker Dose Optimisation Among Patients Attending Heart Failure Clinic at Sarawak Heart Centre, Malaysia
por: Wong, Yii Ching, et al.
Publicado: (2021)

ACE-inhibitors, Beta-blockers or the Combination in Heart Failure: Is It Just an A–B–C ?: EDITORIAL to: Effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
por: de Boer, Rudolf A., et al.
Publicado: (2008)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Interpretability of the European Heart Failure Self-care Behaviour scale
por: Wagenaar, Kim P, et al.
Publicado: (2017)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure
por: Huang, Jin, et al.
Publicado: (2018)

Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
por: Miller, Robert J H, et al.
Publicado: (2016)

β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
por: Liu, Wen-Nan, et al.
Publicado: (2012)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Genetic Polymorphisms in ADRB2 and ADRB1 Are Associated with Differential Survival in Heart Failure Patients Taking β-Blockers
por: Guerra, Leonardo A., et al.
Publicado: (2022)

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
por: Puymirat, Etienne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_djog2ihmhvrso37kb0fcfcsih6